Option Care Health, Inc. Q3 2025 Earnings Recap

OPCH Q3 2025 October 31, 2025

Get alerts when OPCH reports next quarter

Option Care Health reported strong third-quarter performance with a 12% revenue growth, driven by solid contributions from both acute and chronic therapy segments, while making strategic leadership changes to enhance operational efficiency.

Earnings Per Share Beat

$0.45 vs $0.43 est.

+4.7% surprise

Revenue Miss

1435016000 vs 1462834000 est.

-1.9% surprise

Market Reaction

1-Day -0.67%

5-Day +3.34%

30-Day +19.14%

See OPCH alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue increased by 12% year-over-year, significantly outpacing industry growth rates.
Acute therapy revenue growth reached the mid-teens, bolstered by a favorable competitive landscape.
Continued expansion of nursing services, with over 175,000 visits conducted in the quarter, demonstrating efficiency in care delivery.
New partnerships with pharmaceutical manufacturers enhance clinical capabilities and expand the therapy portfolio.
Adjusted 2025 full-year revenue and EBITDA forecasts raised, reflecting ongoing operational strength and favorable market conditions.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit OPCH on AllInvestView.

Previous Q2 2025

Next Q1 2026